1. Anti-proliferative effects of mesenchymal stem cells (MSCs) derived from multiple sources on ovarian cancer cell lines: an in-vitro experimental study
   C. Khalil et al, 2019, Journal of Ovarian Research CrossRef
2. Toll-Like Receptor 2 Expression as a New Hallmark of Advanced Endometriosis
   Małgorzata Sobstyl et al, 2020, Cells CrossRef
3. The combined detection of ovarian cancer biomarkers HE4 and CA125 by a fluorescence and quantum dot dual-signal immunoassay
   Shuange Yao et al, 2019, Analytical Methods CrossRef
4. Exploring the relationship between preeclampsia and human epididymis protein 4
   Gamze Nur Cimilli Senocak et al, 2022, Journal of Surgery and Medicine CrossRef
5. Serum Human Epididymis Protein 4 Combined with Carbohydrate Antigen 125 for Endometrial Carcinoma Diagnosis: A Meta-Analysis and Systematic Review
   Guang-Qing Huang et al, 2019, Genetic Testing and Molecular Biomarkers CrossRef
6. Human epididymis protein 4: Analysis of national health and nutrition examination survey data
   Emily R. Penick et al, 2024, European Journal of Obstetrics & Gynecology and Reproductive Biology CrossRef
7. Development of a longitudinal two-biomarker algorithm for early detection of ovarian cancer in women with BRCA mutations
   Scott E. Lentz et al, 2020, Gynecologic Oncology CrossRef
8. Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta‐analysis
   M Hirsch et al, 2016, BJOG: An International Journal of Obstetrics & Gynaecology CrossRef
9. From Endometriosis to Cancer: Spotlight on Intracellular Signaling Cascades and MicroRNAs
   Talha Abdul Halim et al, 2018, Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs CrossRef
10. The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours
    Qurat ul Ain et al, 2022, Journal of Obstetrics and Gynaecology CrossRef
11. PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis
    Cristian Rodriguez-Aguayo et al, 2019, EBioMedicine CrossRef
12. The clinical significance of the combined detection of serum Smac, HE4 and CA125 in endometriosis-associated ovarian cancer
    Xin-Ran Xu et al, 2018, Cancer Biomarkers CrossRef
13. Machine learning algorithms enhance the specificity of cancer biomarker detection using SERS-based immunoassays in microfluidic chips
    Nariman Banaei et al, 2019, RSC Advances CrossRef
14. Novel diagnostic options for endometriosis – Based on the glycome and microbiome
    Zsuzsanna Kovács et al, 2021, Journal of Advanced Research CrossRef
15. Diagnostic value of urinary-to-serum human epididymis protein 4 ratio in ovarian cancer
    Quming Fan et al, 2017, Biomedical Reports CrossRef
16. Highly elevated human epididymis protein 4 (HE4) following endometrioma rupture: a case report
    Yavuz Emre Şükür et al, 2018, Journal of Obstetrics and Gynaecology CrossRef
17. Factors associated with serum CA125 level in women without ovarian cancer in the United States: a population-based study
    Xiao Hu et al, 2022, BMC Cancer CrossRef
18. Serum Level of Ligand Programmed Death-1 in Endometriosis
    Lyudmila Akhmaltdinova et al, 2022, Open Access Macedonian Journal of Medical Sciences CrossRef
19. HE4 might be a more useful tumor biomarker to detect malignancy in patients with ovarian endometrioma when malignancy is suspected
    Mariona Rius et al, 2021, Journal of International Medical Research CrossRef
20. Gold-silver alloy film based surface plasmon resonance sensor for biomarker detection
    Rumeng Yi et al, 2018, Advanced Sensor Systems and Applications VIII CrossRef
21. Differential molecular pathway expression according to chemotherapeutic response in ovarian clear cell carcinoma
    Min Yin et al, 2023, BMC Women's Health CrossRef
22. Clinical characteristics and prognosis of ovarian clear cell carcinoma: a 10-year retrospective study
    Chenchen Zhu et al, 2021, BMC Cancer CrossRef
23. The performance of Carbohydrate Antigen 125-Thomsen-nouveau and anti-Müllerian hormone combined with CA125, Human epididymis protein 4 and Risk of Malignancy Algorithm in diagnosis for patients with Epithelial ovarian cancer
    Xiuzhu Hou et al, 2023, Clinical Biochemistry CrossRef